Sydney, July 24, 2019 AEST (ABN Newswire) - Anatara's CEO, Steve Lydeamore will be presenting to investors during the Bioshares Biotech Summit this Friday, and at a Monsoon Communications Twilight Investor Briefing event in Melbourne during August. Any investors interested in attending these presentations are invited to reach out.
Details and registration links are summarised below:
Bioshares Biotech Summit
Steve will speak in a session on Gut and the Microbiome alongside Microba and Atmo Biosciences:
* Friday, 26th July 2019
* 5:00pm to 6:00pm
* Skyline, Queenstown, New Zealand
To see the Bioshares program and event information, visit:
http://www.bioshares.com.au/program2019.htm
Monsoon Communications Twilight Investor Briefing
Steve will provide an update on Anatara's work in gastrointestinal health for both humans and animals, alongside AdAlta Ltd:
* Thursday 22nd August 2019
* 4.15pm for 4.30pm
* FB Rice Boardroom, Level 14, 90 Collins Street, Melbourne
To register, contact info@monsoon.com.au
About Anatara Lifesciences Limited
Anatara Lifesciences Limited (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing productsfor human and animal health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders.
| ||
|
